Arena Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Arena Pharmaceuticals's balance sheet done over the years? Its assets were worth $784,705,000 last year, which is less than in the previous period. 14% of Arena Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $111,468,000, which means an increase by 1% compared compared to last year.
Debt to Assets
| 2012 | 261206000 | 162.56M | 62.24% |
|---|---|---|---|
| 2013 | 339807000 | 247.95M | 72.97% |
| 2014 | 276385000 | 229.04M | 82.87% |
| 2015 | 256792000 | 203.25M | 79.15% |
| 2016 | 169010000 | 128.61M | 76.1% |
| 2017 | 339275000 | 132.13M | 38.95% |
| 2018 | 686903000 | 80.64M | 11.74% |
| 2019 | 1174123000 | 102.65M | 8.74% |
| 2020 | 1190720000 | 110.25M | 9.26% |
| 2021 | 784705000 | 111.46M | 14.21% |
ARNA Balance Sheet (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 224.57M | 219.54M | 243.27M | 161.03M | 158.83M | 90.71M | 156.18M | 163.20M | 221.87M | 156.09M |
Short term investments | 325.89M | 884.49M | 496.29M | 284.59M | 88.24M | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 1.65M | 5.08M | 14.38M | 20.16M | 4.93M | 3.71M | 10.60M | 5.55M |
Inventory | 0 | 0 | 0 | 0 | 0 | 6.70M | 9.50M | 10.83M | 12.75M | 6.05M |
Other current assets | 18.99M | 35.26M | 18.71M | 10.00M | 19.82M | 2.30M | 4.21M | 4.14M | 3.57M | 3.45M |
Total current assets | 569.46M | 1.13B | 759.93M | 460.72M | 281.28M | 119.88M | 174.83M | 181.89M | 248.81M | 171.15M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 19.12M | 22.09M | 25.12M | 23.11M | 30.13M | 43.82M | 71.82M | 82.91M | 77.38M | 75.41M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 2.35M | 7.77M | 8.48M | 10.18M | 10.61M |
Long term investments | 160.79M | 0 | 370.93M | 82.41M | 24.24M | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 35.31M | 29.32M | 18.12M | 10.31M | 3.62M | 2.93M | 2.35M | 3.08M | 3.42M | 4.01M |
Total non-current assets | 215.24M | 51.41M | 414.18M | 226.17M | 57.99M | 49.12M | 81.95M | 94.48M | 90.99M | 90.04M |
Total assets | 784.70M | 1.19B | 1.17B | 686.90M | 339.27M | 169.01M | 256.79M | 276.38M | 339.80M | 261.20M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 1.11M | 35.28M | 21.42M | 15.23M | 37.86M | 15.45M |
Short term debt | 5.05M | 4.40M | 3.81M | 3.28M | 4M | 3.51M | 2.97M | 2.49M | 2.05M | 1.66M |
Total current liabilities | 66.31M | 58.07M | 44.96M | 29.91M | 72.32M | 63.87M | 49.89M | 67.36M | 70.74M | 29.91M |
| Non-current liabilities: | ||||||||||
Long term debt | 36.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 8.99M | 52.17M | 57.69M | 50.72M | 58.73M | 62.56M | 65.73M | 68.61M | 75.87M | 85.37M |
Total non-current liabilities | 45.15M | 52.17M | 57.69M | 50.72M | 59.80M | 64.73M | 153.35M | 161.67M | 177.20M | 132.65M |
Total liabilities | 111.46M | 110.25M | 102.65M | 80.64M | 132.13M | 128.61M | 203.25M | 229.04M | 247.95M | 162.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |